Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;34(24):e2201357.
doi: 10.1002/adma.202201357. Epub 2022 May 14.

A Renally Clearable Activatable Polymeric Nanoprobe for Early Detection of Hepatic Ischemia-Reperfusion Injury

Affiliations

A Renally Clearable Activatable Polymeric Nanoprobe for Early Detection of Hepatic Ischemia-Reperfusion Injury

Jiaguo Huang et al. Adv Mater. 2022 Jun.

Abstract

Although hepatic ischemia-reperfusion injury (IRI) represents a major complication in many clinical settings, it remains a diagnostic dilemma due to its reliance on insensitive assays or invasive biopsy. The development of an activatable polymeric nanoprobe (APNSO ) for real-time in vivo near-infrared fluorescence (NIRF) imaging and urinalysis of hepatic IRI is reported here. APNSO has a backbone comprising renally clearable fluorophore fragments and self-immolative structural units. In the presence of an oxidative stress biomarker (superoxide anion, O2 •- ) during hepatic IRI, APNSO can be fluorescently activated for in vivo NIRF imaging and depolymerized to release renally clearable fluorophores for urinalysis. By virtue of its high hepatic accumulation, sensitive response toward O2 •- , and effective release of renally clearable fluorophores, APNSO -based imaging and urinalysis detect hepatic IRI at least 7 h earlier than typical clinical assays in a mouse model. This study not only provides new opportunities for noninvasive diagnosis of hepatic IRI, but also reveals guidelines for the development of optical nanosensors for early urinalysis.

Keywords: activatable polymeric nanoprobe; fluorescence imaging; ischemia-reperfusion injury; liver; renal clearance.

PubMed Disclaimer

References

    1. Y. Zhai, H. Petrowsky, J. C. Hong, R. W. Busuttil, J. W. Kupiec-Weglinski, Nat. Rev. Gastroenterol. Hepatol. 2013, 10, 79.
    1. H. K. Eltzchig, T. Eckle, Nat. Med. 2011, 17, 1391.
    1. J. A. Wertheim, H. Petrowsky, S. Saab, J. W. Kupiec-Weglinski, R. W. Busuttil, Am. J. Transplant. 2011, 11, 1773.
    1. Y. Zhai, R. W. Busuttil, J. W. Kupiec-Weglinski, Am. J. Transplant. 2011, 11, 1563.
    1. D. Neil Granger, P. R. Kvietys, Redox Biol. 2015, 6, 524.

LinkOut - more resources